Current stock page

Stock Analysis

Pfizer Inc. (PFE) Stock Analysis

Pfizer Inc. (PFE) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.

PFE Stock Analysis Summary

Pfizer Inc. (PFE) currently has an AIQ Score of 64/100, indicating a neutral setup. Momentum is the strongest factor at 79/100. Sentiment is the weakest current factor at 50/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Sep 1, 2026 · Market-close data

PFE at a Glance

Crawlable current metrics from the latest market-close stock snapshot.

MetricCurrent
Price$28.55
AIQ Score64/100
Overall ViewNeutral
Technical Analysis ConsensusStrong Buy
Market Cap$151.72B
P/E Ratio8.73
Forward P/E
EPS-$0.04
Revenue TTM$15.03B
Dividend Yield1.72%
Beta0.28
Volume42.57M
52-week range$23.58-$29.09
RSI 1474.45
50-Day SMA$25.71
200-Day SMA$26.11
Analyst Price Target$28.17
Next EarningsNov 3, 2026
As of Sep 1, 2026 · Market close

PFE

Overview
Pfizer Inc.
Healthcare· Drug Manufacturers - General
AIQ Score
NeutralAIQ Edge 9/10
Relative Leader / Watch
Strong Relative Position
Score data as of Sep 1, 2026
Last price
$28.55
+$0.09 (+0.32%)
Latest market quote
Momentum79
Value69
Quality54
Risk Resilience52
Sentiment50
View financial data

PFE Stock Analysis Summary

Pfizer Inc. (PFE) currently has an AIQ Score of 64/100/100, indicating a neutral setup. Momentum is the strongest factor at 79/100/100. Sentiment is the weakest current factor at 50/100/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Sep 1, 2026 · Market-close data
AIQ Composite Posture: Mixed

In a neutral regime, PFE has AIQ Score of 64/100 with Momentum base of 79/100 and fading Sentiment at 50/100. Wait for component alignment before adding exposure.

Signal Conflict Detected

Momentum (79/100) leads while Sentiment (50/100) lags. This cross-factor spread creates entry timing uncertainty.

Healthcare · 0.32% stock move · PFE classified in Drug Manufacturers - General.

Current Evidence

NeutralPFE is in a neutral AIQ regime; Momentum is the strongest visible factor at 79/100.
Core coverage reflects visible evidence only

AlgovestIQ Evidence Summary

Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.

Is PFE Bullish or Bearish Right Now?

PFE currently has a neutral overall setup. Momentum is the strongest factor at 79/100, while Sentiment is weakest at 50/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.

Bull Case
  • - Momentum is constructive at 79/100.
  • - Price is +11.07% above its 50-day SMA.
  • - Technical consensus has more buy votes than sell votes (38 vs 3).
Bear Case
  • - Analyst target implies -1.33% downside from the latest quote.

Current Consensus

PFE's Technical Analysis Consensus is currently Strong Buy, with 38 buy, 4 neutral, and 3 sell votes. PFE's 14-day RSI is 74.45, which places the stock in an overbought momentum range. PFE's beta is 0.28, indicating lower market sensitivity than the broad market.

Signal Confidence
High agreement

What Changed in PFE?

Recent score-change history is not available in the current snapshot. The page still shows the latest market-close evidence and timestamps.

AIQ Score
Momentum
Quality
Risk

What Would Change the PFE Outlook?

The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.

Bullish confirmation

AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.

Bearish deterioration

AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.

PFE Research Cluster

Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.

PFE Fundamentals

PFE valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.

Revenue
$15.03B
Net income
-$246M
Free cash flow
$302M
View full PFE fundamental analysis

PFE Technical Analysis

PFE technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.

Technical Analysis Consensus
Strong Buy
RSI 14
74.45
Price vs SMA-50
+11.07%
View full PFE technical analysis

PFE Stock Catalysts

Track PFE earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.

Next earnings
Nov 3, 2026
Analyst target
$28.17
News items
2
View PFE earnings and stock catalysts

PFE Dividend Analysis

PFE dividend yield, annual dividend, payout ratio, payment history, and income reliability context.

Dividend yield
1.72%
Annual dividend
$1.72
Payout ratio
View PFE dividend history and analysis

PFE Financial Data

PFE revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.

Quarter revenue
$15.03B
EPS
-$0.04
Periods
8
View PFE financials

PFE Risk Analysis

PFE volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.

Beta
0.28
Risk score
52/100
AIQ Score
64/100
View PFE risk analysis

PFE Stock News

PFE stock news, market tone, recent headlines, and catalyst context.

News items
2
Updated
Sep 2, 2026
Sentiment
50/100
Read PFE stock news

Popular PFE Comparisons

How PFE scores against the names it is most often compared with.

About the AIQ Score

Methodology for the current stock evidence.

As of Sep 1, 2026 · Market close

The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.

View AIQ methodology

Factor Diagnostics

A compact bridge from the AIQ score to the evidence tabs.

AIQ Component Profile

Compare the five component scores on one consistent 0–100 scale.

Catalyst preview

Review earnings timing, revisions, news pressure, and prior event reactions in one place.

Open catalysts
Quarterly evidence

8 recent quarterly periods are available for review.

Checked Sep 2, 2026

AIQ Pro

Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.

Fundamentals Verdict

Value and quality should explain the score, not sit behind it.

P/E
35.17
As of Sep 1, 2026
Revenue growth
4.03%
Gross margin
71.32%
Debt / equity
0.74
Latest quarterly evidence

Latest period Jun 28, 2026.

Review fundamentals
Quarter revenue
$15.03B
Quarter net income
-$246M
Quarter free cash flow
$302M

Market Confirmation

Technicals are summarized first, with the indicator library behind it.

Trend
Mixed
Momentum
Bullish
RSI 14
74.45
MACD
0.78

Risk Alignment

Higher resilience is stronger; exposure metrics stay separate.

Resilience
52/100
Beta
0.28
Annual volatility
23.93%
Max drawdown
-17.09%
Recent News
See all news
Sentiment —
No recent news found for PFE

Pfizer Inc. (PFE) Stock Analysis

Snapshot summary of AIQ score, trend, and risk context.

Pfizer Inc. has an AIQ Score of 64/100 in a Neutral regime. Momentum is strongest at 79/100.

The main conflict is that momentum leads at 79/100 while sentiment lags at 50/100. Review the supporting factors together before drawing a conclusion from any single score.

Beta is 0.28, below market sensitivity. Current price is $28.55 and RSI (14) is 74.5.

Regime Context
PFE is in a Neutral AIQ regime with score 64/100.
Signal Conflict
The primary conflict is that momentum leads at 79/100 while sentiment lags at 50/100.
Factor Evidence
Momentum 79/100 · Value 69/100 · Quality 54/100 · Risk 52/100 · Sentiment 50/100
Persistence
Current snapshot evidence is shown; historical persistence remains in AIQ Pro.
Factor strength
Pass
Momentum is the strongest factor at 79/100.
Timing
Pass
Momentum is 79/100 and RSI (14) is 74.5.
Regime fit
Wait
PFE is in a Neutral regime at 64/100.
Risk control
Wait
Risk factor is 52/100 with beta 0.28 and annual volatility 23.93%.
Conflict
Wait
Current conflict: momentum leads at 79/100 while sentiment lags at 50/100.
AIQ Score64/100/100
Price$28.55
Beta0.28
RSI (14)74.5

Compare with Similar Stocks

See how PFE stacks up against its peers
Compare Stocks

Portfolio Implication

PFE currently shows balanced but still concentration-sensitive risk. Beta is 0.28, below market sensitivity.

PFE Stock FAQ

What is PFE stock price today?

Pfizer Inc.'s current stock price is $28.55. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.

Is PFE bullish or bearish right now?

PFE's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.

What is PFE's market cap?

PFE's market cap is $151.72B based on the latest completed market-close snapshot from Sep 1, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.

What is PFE's current P/E ratio?

PFE's current P/E ratio is 8.73 based on the latest completed market-close snapshot from Sep 1, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.

What is PFE's RSI?

PFE's 14-day RSI is 74.45 based on the latest completed market-close snapshot from Sep 1, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.

Is PFE above its 50-day and 200-day moving averages?

PFE is 11.07% from its 50-day SMA and 9.33% from its 200-day SMA based on the latest completed market-close snapshot from Sep 1, 2026. Moving-average position should be read with momentum and broader AIQ evidence.

When is PFE's next earnings date?

PFE's next earnings date is currently listed as Nov 3, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.

Does PFE pay a dividend?

PFE's dividend yield is 1.72% based on the latest completed market-close snapshot from Sep 1, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.